Through the STAT3 pathway, IL-22 which is secreted by CD4+ αβ and γδ T cells, stimulates oncogenic KRAS-driven lung cancer development by promoting a pro-inflammatory microenvironment25. Here, KRAS is linked to lung carcinoma.